Short-term impact of HbA1c on morbidity and all-cause mortality in people with type 2 diabetes: a Danish population-based observational study

No evidence of an increased mortality risk associated with low levels of glycated haemoglobin in a non-diabetic UK population

(2011) R. Pfister et al.   DIABETOLOGIA

Low Hemoglobin A1c and Risk of All-Cause Mortality Among US Adults Without Diabetes

(2010) April P. Carson et al.  

Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study

(2010) Craig J Currie et al.   LANCET

Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults

(2010) Elizabeth Selvin et al.   NEW ENGLAND JOURNAL OF MEDICINE

International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes

(2009)   DIABETES CARE

Relationship between glycated haemoglobin and microvascular complications: Is there a natural cut-off point for the diagnosis of diabetes?

(2009) C. Sabanayagam et al.   DIABETOLOGIA

Intensive glucose control and macrovascular outcomes in type 2 diabetes

(2009) F. M. Turnbull et al.   DIABETOLOGIA

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

(2009) Kausik K Ray et al.   LANCET

Review of hemoglobin A1c in the management of diabetes

(2009) Emily Jane GALLAGHER et al.   Journal of Diabetes

Longitudinal Association of Glucose Metabolism With Retinopathy: Results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study

(2008) R. J. Tapp et al.   DIABETES CARE